Atea Pharmaceuticals, Inc. (AVIR)
Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.
Address
225 FRANKLIN STREET
BOSTON, MA 02110
Founded
2012
Number of Employees
75
Website
http://www.ateapharma.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)